Today's RGBP PR makes my blood boil. No date of c
Post# of 373
Posted On: 09/10/2014 10:52:02 AM
Re: Stock_Tracker #18
Today's RGBP PR makes my blood boil. No date of call, no time frame for extra safety trial, no info on how this will impact dCellVax IND.
Nothing substantial other than verifying what we should have been told weeks or months ago. Or even worse, they just talked to the FDA about what they need to do 5 months after resubmitting their modified IND on May 6th.
It takes 4 months to get an empty PR with no substantial info on what, how long or when their first major drug could be resubmitted to FDA for clinical trial approval.
I just sold 90% of my BMSN holdings at a huge loss this morning as I'm sick of this.
Holding on to the free divvy shares in case this eventually gets some kind of act together.
The writing on the wall was clear (see my previous posts) from previous PRs that Koos was skirting the issue of time and clarity and he still has. I supposed they needed further data studies when Koos said "clarification" and many denied that possibility. Well, we just found out we are not closer, but further away from clinical trials today.
Nothing substantial other than verifying what we should have been told weeks or months ago. Or even worse, they just talked to the FDA about what they need to do 5 months after resubmitting their modified IND on May 6th.
It takes 4 months to get an empty PR with no substantial info on what, how long or when their first major drug could be resubmitted to FDA for clinical trial approval.
I just sold 90% of my BMSN holdings at a huge loss this morning as I'm sick of this.
Holding on to the free divvy shares in case this eventually gets some kind of act together.
The writing on the wall was clear (see my previous posts) from previous PRs that Koos was skirting the issue of time and clarity and he still has. I supposed they needed further data studies when Koos said "clarification" and many denied that possibility. Well, we just found out we are not closer, but further away from clinical trials today.
(0)
(0)